Weisberg, Ellen http://orcid.org/0000-0002-5679-9531
Meng, Chengcheng
Case, Abigail
Sattler, Martin
Tiv, Hong L.
Gokhale, Prafulla C.
Buhrlage, Sara
Wang, Jinhua
Gray, Nathanael http://orcid.org/0000-0001-5354-7403
Stone, Richard
Liu, Suiyang
Bhagwat, Shripad V.
Tiu, Ramon V.
Adamia, Sophia
Griffin, James D.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 21 May 2019
Revised: 7 June 2019
Accepted: 26 June 2019
First Online: 27 August 2019
Change Date: 6 March 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-020-0782-4
Compliance with ethical standards
:
: JDG receives funding and has received a royalty payment from Novartis Pharmaceuticals and receives funding from Eli Lilly and Company. N is a founder, science advisory board member (SAB), and equity holder in Gatekeeper, Syros, Petra, C4, B2S, and Soltego. The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Her2llc, Deerfield, and Sanofi. EW has received a royalty payment from Novartis Pharmaceuticals. RS does Ad Hoc consulting for and receives clinical research support to Dana-Farber Cancer Institute from the following companies: Abbvie, Agios, Arog, and Novartis. He does Ad Hoc consulting for the following companies: Astrazeneca, Cornerstone, Jazz, Daiichi-Sankyo, Otsuka/Astex, Pfizer, and Stemline. He is on the Advisory Board of the following companies: Actinium, Amgen, Astellas, and Macrogenics. He is on the Data Safety and Monitoring Board for the following companies: Argenx, Celgene, and Takeda. He is an Ad Hoc Consultant and on the Steering Committee and Data Safety and Monitoring Board for Celgene. SVB is an employee and shareholder of Eli Lilly and Company. RVT was an employee and is a shareholder of Eli Lilly and Company, and is currently employed by Astellas Pharma.